Yoshida, S.; Takahara, T.; Arita, Y.; Toda, K.; Kimura, K.; Tanaka, H.; Yokoyama, M.; Matsuoka, Y.; Yoshimura, R.; Fujii, Y.
Impact of Progressive Site-Directed Therapy in Oligometastatic Castration-Resistant Prostate Cancer on Subsequent Treatment Response. Cancers 2022, 14, 567.
https://doi.org/10.3390/cancers14030567
AMA Style
Yoshida S, Takahara T, Arita Y, Toda K, Kimura K, Tanaka H, Yokoyama M, Matsuoka Y, Yoshimura R, Fujii Y.
Impact of Progressive Site-Directed Therapy in Oligometastatic Castration-Resistant Prostate Cancer on Subsequent Treatment Response. Cancers. 2022; 14(3):567.
https://doi.org/10.3390/cancers14030567
Chicago/Turabian Style
Yoshida, Soichiro, Taro Takahara, Yuki Arita, Kazuma Toda, Koichiro Kimura, Hajime Tanaka, Minato Yokoyama, Yoh Matsuoka, Ryoichi Yoshimura, and Yasuhisa Fujii.
2022. "Impact of Progressive Site-Directed Therapy in Oligometastatic Castration-Resistant Prostate Cancer on Subsequent Treatment Response" Cancers 14, no. 3: 567.
https://doi.org/10.3390/cancers14030567
APA Style
Yoshida, S., Takahara, T., Arita, Y., Toda, K., Kimura, K., Tanaka, H., Yokoyama, M., Matsuoka, Y., Yoshimura, R., & Fujii, Y.
(2022). Impact of Progressive Site-Directed Therapy in Oligometastatic Castration-Resistant Prostate Cancer on Subsequent Treatment Response. Cancers, 14(3), 567.
https://doi.org/10.3390/cancers14030567